Literature DB >> 35733044

A Novel Dynamic Human In Vitro Model for Studying the Blood-Brain Barrier.

Patricia Miranda-Azpiazu1, Sikha Saha2.   

Abstract

Constructing a reliable in vitro blood-brain barrier (BBB) model using human primary cells has been considered a major challenge during the past decades. These systems could provide valuable information regarding the effect of therapeutic compounds on different BBB cell types (endothelial cells, astrocytes, pericytes) and their ability to cross the barrier in order to reach the brain. Several attempts have been made to develop in vitro BBB models, but these studies mainly used rat, bovine, and porcine cells rather than human primary cells. Genetically modified cell lines have also been used, but they do not appear to maintain physiological properties of the BBB. Here, we describe a detailed protocol for co-culturing and maintaining human brain primary endothelial cells, pericytes, and astrocytes under flow to create an in vitro human BBB model, which can be used for toxicity testing and for studying cross-interaction among different cell types involved in the BBB formation.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Astrocytes; Blood–brain barrier (BBB); Cell culture; Conditioned media; Endothelial cells; Human primary cell; Multicellular organ flow system; Pericytes; Quasi-Vivo system; Shear stress

Mesh:

Year:  2022        PMID: 35733044     DOI: 10.1007/978-1-0716-2289-6_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  [The Blood-Brain Barrier (BBB) and in vitro BBB Models].

Authors:  Yukio Takeshita; Takashi Kanda
Journal:  Brain Nerve       Date:  2015-08

2.  A novel dynamic multicellular co-culture system for studying individual blood-brain barrier cell types in brain diseases and cytotoxicity testing.

Authors:  Patricia Miranda-Azpiazu; Stavros Panagiotou; Gin Jose; Sikha Saha
Journal:  Sci Rep       Date:  2018-06-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.